CD137 as a biomarker for tumor-reactive T cells: Finding gold in the desert

Yuwen Zhu, Lieping Chen

Research output: Contribution to journalArticlepeer-review

Abstract

Although human cancer is often surrounded by immune cells, only a small number are tumor-reactive T cells that recognize the tumor antigens and are able to eliminate the cancer cells. Ye and colleagues now found that many of these tumor-reactive T cells are marked by expressing CD137, a T-cell costimulatory receptor. Clin Cancer Res; 20(1); 3-5.

Original languageEnglish (US)
Pages (from-to)3-5
Number of pages3
JournalClinical Cancer Research
Volume20
Issue number1
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'CD137 as a biomarker for tumor-reactive T cells: Finding gold in the desert'. Together they form a unique fingerprint.

Cite this